Old Web
English
Sign In
Acemap
>
Paper
>
VEGF/VEGFRs nasal expression is reduced by Mepolizumab in chronic rhinosinusitis with nasal polyposis.
VEGF/VEGFRs nasal expression is reduced by Mepolizumab in chronic rhinosinusitis with nasal polyposis.
2021
Carlo Cavaliere
Simonetta Masieri
Antonio Greco
Alessandro Lambiase
Marco Segatto
Keywords:
Interleukin 5
chronic rhinosinusitis
Immunology
Mepolizumab
severe asthma
Medicine
VEGF receptors
Correction
Source
Cite
Save
Machine Reading By IdeaReader
10
References
0
Citations
NaN
KQI
[]